Health insurance; pharmacy benefits managers, definition of "covered entity."
HB2392 amends Virginia’s insurance code definition section governing pharmacy benefits managers (PBMs). The bill updates and expands several key definitions used in the PBM article, including “carrier,” “claim,” “claims processing services,” “covered entity,” “covered individual,” “health benefit plan,” “mail order pharmacy,” “pharmacy benefits management,” “pharmacy benefits manager,” “pharmacy benefits manager affiliate,” “rebate,” “retail community pharmacy,” “retained rebate,” “retained rebate percentage,” and “spread pricing.” It also adds a definition for “contract pharmacy” tied to federal 340B guidance and clarifies that a “covered entity” means a 340B-covered entity under federal law, while excluding hospitals from that definition.
The practical effect of the bill is to refine the legal framework Virginia uses to regulate PBM conduct and related prescription drug pricing practices. By defining terms such as retained rebates and spread pricing, the bill supports enforcement and interpretation of existing PBM-related requirements and helps distinguish between entities and business models involved in prescription drug distribution, reimbursement, and rebate flow. The bill also expressly includes PBM affiliates and entities acting for PBMs in certain contexts, broadening the reach of the regulatory definitions.
The bill appears to have been broadly supported throughout the legislative process. It advanced unanimously in subcommittee and committee, passed the House 99-0, and passed the Senate 40-0, indicating strong bipartisan agreement and little visible opposition in recorded votes. The absence of committee transcript material limits insight into detailed debate, but the vote history suggests the measure was viewed as a technical or clarifying update rather than a controversial policy change.
Because the bill focuses on definitions, the main points of contention would likely center on how broadly PBM regulation should extend, especially regarding affiliates, contract pharmacies, and the treatment of rebates and spread pricing. The exclusion of hospitals from the definition of covered entity and the incorporation of federal 340B terminology may also matter to hospitals, safety-net providers, pharmacies, PBMs, insurers, and third-party payors, but no recorded opposition appears in the available history.
HB2392 amends § 38.2-3465 of the Code of Virginia, which is part of the state’s PBM regulatory article. The bill changes state law by revising and adding definitions that will govern how PBM-related provisions are interpreted and applied, including terms tied to rebates, spread pricing, contract pharmacies, and covered entities under the federal 340B program. These definitional updates affect PBMs, carriers, pharmacies, covered entities, and health benefit plans by clarifying the scope of regulated conduct and the entities subject to the statute.
The overall sentiment around HB2392 was strongly positive and largely noncontroversial. It moved through subcommittee, committee, and both chambers with unanimous or near-unanimous votes, suggesting broad legislative consensus. The available record does not show any recorded dissent or substantive opposition, and the bill’s passage appears to reflect agreement on the need to clarify PBM-related statutory definitions.
No formal contention is reflected in the available votes or transcripts, but the subject matter implicates recurring policy disputes over pharmacy benefits managers, prescription drug pricing, rebates, spread pricing, and 340B contract pharmacy arrangements. Stakeholders most likely to care about the definitions include PBMs, insurers/carriers, retail community pharmacies, mail order pharmacies, hospitals, nonprofit health systems, and 340B-covered entities. The exclusion of hospitals from the definition of covered entity and the inclusion of PBM affiliates and contract pharmacy concepts are the provisions most likely to draw scrutiny if any disagreement were to arise.